Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice

Molecular Nutrition and Food Research

Volumn 55, Issue 4, 2011, Pages 530-540

  Kobori, Masuko ^a   Masumoto, Saeko ^a   Akimoto, Yukari ^a   Oike, Hideaki ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Liver steatosis; Metabolic disorder; Oxidative stress; Quercetin; Western diet

Indexed keywords

GLUTATHIONE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; QUERCETIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; C57BL MOUSE; DIET; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; LIVER; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

ADIPOSITY; ANIMALS; DIET; FATTY LIVER; GENE EXPRESSION REGULATION; GLUTATHIONE; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OBESITY; OXIDATIVE STRESS; PPAR ALPHA; QUERCETIN; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TRIGLYCERIDES;

MUS;

EID: 79953317030     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000392     Document Type: Article

References (50)

1. Pereira, M. A., Kottke, T. E., Jordan, C., O'Connor, P. J. et al., Preventing and managing cardiometabolic risk: the logic for intervention. Int. J. Environ. Res. Public Health 2009, 6, 2568-2584.
2. van Dam, R. M., Rimm, E. B., Willett, W. C., Stampfer, M. J., Hu, F. B., Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann. Intern. Med. 2002, 136, 201-209.
3. Heidemann, C., Schulze, M. B., Franco, O. H., van Dam, R. M. et al., Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation 2008, 118, 230-237.
4. Boden-Albala, B., Elkind, M. S., White, H., Szumski, A. et al., Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology 2009, 32, 296-301.
5. Buettner, R., Scholmerich, J., Bollheimer, L. C., High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15, 798-808.
6. van Baak, M. A., Astrup, A., Consumption of sugars and body weight. Obes. Rev. 2009, 10, 9-23.
7. Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L. et al., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895-909.
8. Arts, I. C., Hollman, P. C., Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S-325S.
9. Grassi, D., Aggio, A., Onori, L., Croce, G. et al., Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J. Nutr. 2008, 138, 1554S-1560S.
10. Dufour, C., Loonis, M., Flavonoids and their oxidation products protect efficiently albumin-bound linoleic acid in a model of plasma oxidation. Biochim. Biophys. Acta 2007, 1770, 958-965.
11. Meyers, K. J., Rudolf, J. L., Mitchell, A. E., Influence of dietary quercetin on glutathione redox status in mice. J. Agric. Food Chem. 2008, 56, 830-836.
12. Kobori, M., Masumoto, S., Akimoto, Y., Takahashi, Y., Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 2009, 53, 859-868.
13. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J. M. et al., Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. USA 1998, 95, 9831-9836.
14. Hosokawa, N., Hirayoshi, K., Kudo, H., Takechi, H. et al., Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol. Cell. Biol. 1992, 12, 3490-3498.
15. van Meeuwen, J. A., Korthagen, N., de Jong, P. C., Piersma, A. H., van den Berg, M., (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol. Appl. Pharmacol. 2007, 221, 372-383.
16. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W. et al., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425, 191-196.
17. Rivera, L., Moron, R., Sanchez, M., Zarzuelo, A., Galisteo, M., Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16, 2081-2087.
18. Stewart, L. K., Wang, Z., Ribnicky, D., Soileau, J. L. et al., Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia 2009, 52, 514-523.
19. Harwood, M., Danielewska-Nikiel, B., Borzelleca, J. F., Flamm, G. W. et al., A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45, 2179-2205.
20. de Boer, V. C., Dihal, A. A., van der Woude, H., Arts, I. C. et al., Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005, 135, 1718-1725.
21. Radonjic, M., de Haan, J. R., van Erk, M. J., van Dijk, K. W. et al., Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program. PLoS One 2009, 4, e6646.
22. Feillet-Coudray, C., Sutra, T., Fouret, G., Ramos, J. et al., Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic. Biol. Med. 2009, 46, 624-632.
23. Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B., Bailey, S. M., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 2008, 44, 1259-1272.
24. Perez-Carreras, M., Del Hoyo, P., Martin, M. A., Rubio, J. C. et al., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 38, 999-1007.
25. Milagro, F. I., Campion, J., Martinez, J. A., Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 2006, 14, 1118-1123.
26. Fujita, K., Nishizawa, H., Funahashi, T., Shimomura, I., Shimabukuro, M., Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ. J. 2006, 70, 1437-1442.
27. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111, 1448-1454.
28. Kumashiro, N., Tamura, Y., Uchida, T., Ogihara, T. et al., Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance. Diabetes 2008, 57, 2083-2091.
29. Capeau, J., Insulin resistance and steatosis in humans. Diabetes Metab. 2008, 34, 649-657.
30. Sekiya, M., Hiraishi, A., Touyama, M., Sakamoto, K., Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem. Biophys. Res. Commun. 2008, 375, 602-607.
31. Lin, C. C., Yin, M. C., Effects of cysteine-containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet. Br. J. Nutr. 2008, 99, 37-43.
32. Aragno, M., Tomasinelli, C. E., Vercellinatto, I., Catalano, M. G. et al., SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic. Biol. Med. 2009, 47, 1067-1074.
33. Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A. et al., Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55, 2180-2191.
34. Browning, J. D., Horton, J. D., Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114, 147-152.
35. Eid, H. M., Martineau, L. C., Saleem, A., Muhammad, A. et al., Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res. 2010, 54, 991-1003.
36. Ahn, J., Lee, H., Kim, S., Park, J., Ha, T., The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373, 545-549.
37. Knopp, R. H., Drug treatment of lipid disorders. N. Engl. J. Med. 1999, 341, 498-511.
38. Kersten, S., Desvergne, B., Wahli, W., Roles of PPARs in health and disease. Nature 2000, 405, 421-424.
39. Le Marchand-Brustel, Y., Gual, P., Gremeaux, T., Gonzalez, T. et al., Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem. Soc. Trans. 2003, 31, 1152-1156.
40. Yu, S., Matsusue, K., Kashireddy, P., Cao, W. Q. et al., Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 2003, 278, 498-505.
41. Inoue, M., Ohtake, T., Motomura, W., Takahashi, N. et al., Increased expression of PPAR gamma in high fat diet-induced liver steatosis in mice. Biochem. Biophys. Res. Commun. 2005, 336, 215-222.
42. Gomez-Valades, A. G., Mendez-Lucas, A., Vidal-Alabro, A., Blasco, F. X. et al., Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 2008, 57, 2199-2210.
43. Kadowaki, T., Yamauchi, T., Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26, 439-451.
44. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K. et al., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116, 1784-1792.
45. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M. et al., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114, 1752-1761.
46. Houstis, N., Rosen, E. D., Lander, E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440, 944-948.
47. Polyzos, S. A., Kountouras, J., Zavos, C., Tsiaousi, E., The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes. Metab. 12, 365-383.
48. Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259, 87-91.
49. Shibasaki, M., Takahashi, K., Itou, T., Miyazawa, S. et al., Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 2002, 45, 518-526.
50. Osada, K., Suzuki, T., Kawakami, Y., Senda, M. et al., Dose-dependent hypocholesterolemic actions of dietary apple polyphenol in rats fed cholesterol. Lipids 2006, 41, 133-139.